Management of Cardiogenic Shock in a Cardiac Intensive Care Unit

Methodist Debakey Cardiovasc J. 2020 Jan-Mar;16(1):36-42. doi: 10.14797/mdcj-16-1-36.


Cardiogenic shock (CS) is a complex condition characterized by end-organ hypoperfusion and requiring pharmacologic and/or mechanical circulatory support. It is caused by a decline in cardiac output due to a primary cardiac disorder. CS is frequently complicated by multiorgan system dysfunction that requires a multidisciplinary approach in a critical care setting. Appropriate use of diagnostic data using tools available in a modern cardiac intensive care unit should guide optimal management incorporating both pharmacologic and nonpharmacologic therapies to minimize morbidity and mortality.

Keywords: acute myocardial infarction; cardiogenic shock; critical care; heart failure; pulmonary artery catheterization.

Publication types

  • Review

MeSH terms

  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Catheterization, Swan-Ganz
  • Combined Modality Therapy
  • Critical Care*
  • Hemodynamics*
  • Hospital Mortality
  • Humans
  • Intensive Care Units*
  • Predictive Value of Tests
  • Recovery of Function
  • Respiration, Artificial* / adverse effects
  • Respiration, Artificial* / mortality
  • Risk Factors
  • Shock, Cardiogenic / diagnosis
  • Shock, Cardiogenic / mortality
  • Shock, Cardiogenic / physiopathology
  • Shock, Cardiogenic / therapy*
  • Treatment Outcome
  • Ultrafiltration* / adverse effects
  • Ventricular Function*


  • Cardiovascular Agents